Patricia van den Hoogen

Acquired mutations in TET2 are common in myelodysplastic syndromes

Saskia Langemeijer, Roland P. Kuiper, M Berends et al. · Nature Genetics · 2009 · 740 citations

Hematological Malignancy, Genetic Disorder, Medicine +6

Intramyocardial stem cell injection: go(ne) with the flow

F. van den Akker, Dries Feyen, Patricia van den Hoogen et al. · European Heart Journal · 2016 · 82 citations · Full text

Tissue Engineering, Heart Failure, Engineering +16

Increased circulating IgG levels, myocardial immune cells and IgG deposits support a role for an immune response in pre‐ and end‐stage heart failure

Patricia van den Hoogen, Saskia C.A. de Jager, Manon M. H. Huibers et al. · Journal of Cellular and Molecular Medicine · 2019 · 46 citations · Full text

Clinical and biological impact of TET2 mutations and expression in younger adult AML patients treated within the EORTC/GIMEMA AML-12 clinical trial

Mariam G. Aslanyan, Leonie I. Kroeze, Saskia Langemeijer et al. · Annals of Hematology · 2014 · 30 citations

Tumor Biology, Medicine, Immunology +6

Heart Failure in Chronic Myocarditis: A Role for microRNAs?

Patricia van den Hoogen, F. van den Akker, Janine C. Deddens et al. · Current Genomics · 2015 · 28 citations · Full text

Translational Medicine, Heart Failure, Cardiomyopathy +13